Newsroom

Learn more about Recolony bacteria-based cancer therapy, plus never miss an event.

Apr 20, 20231 min read

Recolony gets featured by Handelzeitung

Philipp Busenhart, CBO of Recolony, presents our company in this interview with the Handelzeitung

Feb 23, 20231 min read

Recolony wins the Stage III of Venture Kick. Recolony will invest the CHF 150,000 awarded by Venture Kick to advance our small molecule...

Sep 14, 20221 min read

SWICA September Newsletter includes an article about Recolony Source: Swiss.ch

Sep 11, 20220 min read

Apr 21, 20221 min read

Ana Montalban-Arques got interviewed by the University of Zurich to talk about our bacteria-based cancer therapy for the treatment of...

Feb 11, 20221 min read

Our CEO Ana Montalban-Arques is awarded with one of the Lyceum Awards to young women scientists in the category of Health Sciences. She...

Jan 25, 20221 min read

Within the section "From lab to market" of the Werner Siemens Stiftung annual report 2021, our CEO Ana Montalban-Arques explains the...

Oct 15, 20211 min read

Our article "Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors" is highlighted in the...